Tirzepatide Drug Interactions and Safety

Introduction to Tirzepatide

Tirzepatide has few clinically significant drug interactions, with the most important consideration being potential delayed absorption of oral medications with narrow therapeutic indices due to its effects on gastric emptying 1
The mechanism of tirzepatide significantly slows gastric emptying, which may delay absorption of oral medications 1

For oral hormonal contraception, the American Diabetes Association recommends using or adding a non-oral contraception method for 4 weeks after tirzepatide initiation and dose escalations 2
For warfarin, the American Heart Association suggests monitoring INR more closely after tirzepatide initiation or dose changes 2, 3
Tirzepatide appears to have minimal interactions with statins, antihypertensive medications, and most antiarrhythmic agents 3
When tirzepatide is used with bile acid sequestrants, separate administration by at least 4-6 hours to prevent potential binding that could reduce tirzepatide absorption 4

When tirzepatide is combined with sulfonylureas or insulin, there is an increased risk of hypoglycemia; consider dose reduction of these agents 5
The American College of Cardiology notes that tirzepatide has no significant interaction concerns with SGLT2 inhibitors; combination may provide complementary benefits 5
Tirzepatide has no significant interactions with DPP4 inhibitors, but limited additional benefit when used together 5

Tirzepatide has a long half-life (approximately 5 days), making it less susceptible to short-term interaction effects 1
Unlike some medications, tirzepatide is not significantly metabolized by cytochrome P450 enzymes, does not inhibit or induce major drug metabolizing enzymes, and has minimal renal elimination of intact drug 1

Patients with renal impairment should use caution when initiating or increasing dose due to potential risk of acute kidney injury 2
Patients with a history of pancreatitis should be monitored for signs of pancreatitis, though causality has not been established 2
Patients with gallbladder disease may be at risk of cholelithiasis and gallstone-related complications 2